Special camellia oleosa seed oil skin care cream for infantile infantile eczema as well as preparation method and application thereof
By developing special baby tea seed oil skin care cream, combined with emulsification technology of polar and non-polar ingredients, the problems of large viscosity of existing baby skin care products and adverse reactions to hormone drugs have been solved, and the effect of quickly repairing the skin barrier of babies is achieved. , provides a safe and effective natural skin care product.
Patent Information
- Application Number
- CN202411014567.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-26
- Publication Date
- 2024-11-15
AI Technical Summary
Current baby skin care products have large viscosity, large droplet diameter and wide particle size distribution range when treating tinea larvae. They have poor sensory effects, and often use hormone drugs to cause adverse reactions, and lack natural ingredient skin care products for babies.
Develop a special baby tea seed oil skin care cream, containing components of polar and non-polar phases, such as water, glycerin, polyglycerin-6 stearate, tea seed oil, cetacean olive oleate, etc. , prepared by mechanical stirring and high-pressure homogeneous emulsification technology, form an emulsion to avoid sensitization ingredients such as flavors and alcohol, and add honey tangerine peel extract and vitamin E to enhance the anti-inflammatory repair effect.
This skin care cream can quickly repair damaged skin barriers, is safe and effective, and is similar to hormone ointment but has no adverse reactions. It is suitable for long-term use, and the skin feels light and moisturizing, which significantly relieves the symptoms of infant eczema.
Smart Images

Figure CN118948680A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the fields of daily chemicals and skin care products, and in particular to a camellia oil skin care cream for babies, a preparation method thereof and uses thereof. The skin care cream can effectively relieve milk eczema in babies, and solves the problems of existing camellia oil baby skin care products for baby milk eczema, such as viscosity, large emulsion droplet diameter and wide particle size distribution range, and unsatisfactory sensory effects. Background Art
[0002] Milk ringworm, known as infantile eczema in modern medicine, is one of the common skin diseases in infants and young children, with a high incidence rate. At the beginning of milk ringworm, the skin may become red, rash, itchy, and exudate yellow fluid, followed by rough skin and scabs, and may also be accompanied by fever, irritability and other damp-heat symptoms. If milk ringworm is not controlled in time, it can spread to the entire face, forehead, neck, etc., and in acute attacks, the itching is unbearable, affecting the infant's eating and sleeping, and further affecting normal development.
[0003] Children's skin is delicate and needs special care, especially in winter and summer. Improper care can easily cause problems and even lead to diseases. Most children's skin lacks water and oil. In the hot summer and dry winter, the moisture of the skin is easily evaporated. Especially in summer, every degree of temperature increase will cause 10% loss of skin moisture and oil, resulting in holes in the skin's natural protective barrier - the lanolin membrane, which will stimulate the oil glands to secrete more oil to fill the holes, resulting in a lack of water and oil, cracks in the stratum corneum and loosening, and the ability to resist external stimuli is reduced, causing various skin problems. Therefore, to open up children's "skin waterway", it is necessary to choose skin care products containing skin-friendly oil ingredients.
[0004] Skin care products that have the function of repairing the skin barrier can restore the skin's lanolin membrane, reduce transepidermal water loss, increase the skin's water content, and rebuild the skin barrier, thereby relieving dry skin, itching and other discomforts. At the same time, they can help anti-inflammatory drugs to work, improve the efficacy of anti-inflammatory drugs, reduce the incidence of adverse reactions, and shorten the recovery time. At present, skin care products have been used in combination with drugs to treat infantile eczema, and have achieved good therapeutic effects.
[0005] At present, the treatment of infant eczema generally adopts the prevention and treatment method of oral administration plus external application. Because it is not easy to choose medicine for infants and young children, clinical topical medicines often contain glucocorticoids or histamine antiallergic drugs, but there are many side effects, which can easily lead to systemic or local adverse reactions. If topical hormone preparations are used in large doses for a long time or in a short period of time, it will also cause drug-dependent dermatitis. The combination of skin care products with traditional Chinese medicine preparations and hormone drugs reduces the dosage of drugs and has achieved good results in clinical practice. However, hormone drugs are related to the safety of infant medication and are likely to cause adverse reactions to infants and young children.
[0006] There are many skin care products for the treatment of eczema on the market, such as Avène Triple Repair Cream, which contains rhamnoside and triple moisturizing formula, and adds natural moisturizing oils such as safflower seed oil, coconut oil, and evening primrose oil, which can effectively replenish the lipid loss when the skin barrier is damaged. The use of natural spring water can timely replenish calcium ions from the damaged stratum corneum to the basal layer to maintain the homeostasis of the skin barrier. However, the Avène repair cream product is mainly developed for adult sensitive skin. Therefore, it is urgent to develop a skin care product with natural ingredients that can completely target infant milk ringworm. Summary of the invention
[0007] In view of the problems existing in the above-mentioned prior art, the purpose of the present invention is to provide a skin care product with natural ingredients that can specifically treat infantile milk ringworm, and its preparation method and use. The skin care product can solve the shortcomings of the prior art such as the use of hormone drugs.
[0008] To solve the above technical problems, according to one aspect of the present invention, an object of the present invention is to provide a camellia oil skin care cream for babies, which comprises a polar phase and a non-polar phase, wherein the polar phase comprises water, glycerin, polyglycerol-6 stearate, sorbitan olivate, 1,2-ethylene glycol, carbomer, vitamin E, and arginine; and the non-polar phase comprises primary camellia oil, cetearyl olivate, caprylic / capric triglyceride, sunflower seed oil, cetearyl alcohol, p-hydroxyacetophenone, and tangerine peel extract.
[0009] Preferably, based on 100 parts by weight of the skin care cream, the polar phase includes the following ingredients in parts by weight: 60-80 parts by weight of water, 0.05-5 parts by weight of glycerin, 0.5-5 parts by weight of polyglycerol-6 stearate, 0.5-15.0 parts by weight of sorbitan olivate, 0.05-1 parts by weight of 1,2-ethylene glycol, 0.1-2 parts by weight of carbomer, 0.2-1.8 parts by weight of vitamin E, 0 .05-0.1 weight parts of arginine; the non-polar phase comprises 2-30 weight parts of first-grade camellia oil, 0.2-1.8 weight parts of cetearyl olive oil ester, 3-7 weight parts of caprylic / capric triglyceride, 0.15-0.3 weight parts of sunflower oil, 0.8-1.7 weight parts of cetearyl alcohol, 0.2-0.5 weight parts of p-hydroxyacetophenone, and 0.1-0.3 weight parts of mandarin orange peel extract.
[0010] More preferably, based on 100 parts by weight of the skin care cream, the following ingredients are included in weight: 73-78 parts by weight of water, 0.06-0.08 parts by weight of glycerin, 1.5-1.8 parts by weight of polyglyceryl-6 stearate, 0.98-1.50 parts by weight of sorbitan olive oil ester, 0.1-0.3 parts by weight of 1,2-ethylene glycol, 0.15-0.25 parts by weight of carbomer, and 0.95-1.6 parts by weight of vitamin E. , 0.07-0.09 weight parts of arginine; the non-polar phase comprises 11-13 weight parts of first-grade camellia oil, 1.1-1.5 weight parts of cetearyl olive oil ester, 4.8-5.2 weight parts of caprylic / capric triglyceride, 0.15-0.3 weight parts of sunflower oil, 0.95-1.3 weight parts of cetearyl alcohol, 0.3-0.4 weight parts of p-hydroxyacetophenone, and 0.1-1 weight parts of mandarin orange peel extract.
[0011] According to another aspect of the present invention, another object of the present invention is to provide a method for preparing the camellia oil skin care cream for babies, the method comprising the following steps:
[0012] 1) Weighing various ingredients of the skin care cream according to proportion;
[0013] 2) Mix the components of the polar phase and stir at 70-85°C to completely dissolve them;
[0014] 3) Mix the components of the non-polar phase and stir at 90-110° C. to make them uniformly mixed;
[0015] 4) The polar phase and the non-polar phase obtained in steps 2) and 3) are emulsified by mechanical stirring, high-pressure homogenization emulsification, microfluidization emulsification or microfluidic emulsification to form an emulsion, and then the obtained mixed emulsion is vacuum degassed and gradually cooled to 25-50° C. to obtain a skin care cream.
[0016] Preferably, the stirring speed of each component of the polar phase in step 2) during the stirring and dissolving process is 4000-7000 rpm. Due to the presence of multiple components in the polar phase, the viscosity is relatively high, and controlling the stirring speed within the above range can effectively promote the dissolution of the components.
[0017] Preferably, the stirring speed of the non-polar phase in step 3) during the stirring and dissolving process is 5000-8000 rpm. Due to the presence of multiple components in the polar phase, the viscosity is relatively high, and controlling the stirring speed within the above range can effectively promote the dissolution of the components.
[0018] Preferably, the emulsification method in step 4) is one of high-pressure homogenization emulsification, microfluidization emulsification, and microfluidic emulsification.
[0019] According to another aspect of the present invention, another object of the present invention is to provide the use of the camellia oil skin care cream for infants as a medicine for treating or alleviating infant eczema.
[0020] Beneficial Effects
[0021] The formula of the camellia oil skin care cream for babies according to the present invention does not contain allergenic ingredients such as flavors, alcohol, and pigments, and the preservative system has no adverse reactions. In addition, camellia oil contains a variety of anti-inflammatory and repairing ingredients such as tocopherol and squalane. The human body efficacy evaluation results show that the product can quickly repair damaged skin barriers and has both safety and effectiveness. The baby milk ringworm repair cream of the present invention adds the above-mentioned multiple natural ingredients, which can achieve the same efficacy as hormone ointments, can be used for a long time, feel light and moisturizing, and can effectively protect the delicate skin of babies. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.
[0023] Figure 1 The present invention is a diagram showing the preparation process of the skin care cream for infant milk ringworm according to the present invention.
[0024] Figure 2 Schematic diagram of the process of the moisturizing cream repairing the skin according to the present invention.
[0025] Figure 3 These are the before and after pictures of applying the moisturizing cream in implementation case 2.
[0026] Figure 4 This is a comparison of the effects of the moisturizing creams obtained in Examples 1-3 on milk eczema (infant eczema). DETAILED DESCRIPTION
[0027] Hereinafter, the present invention will be described in detail. Before describing, it should be understood that the terms used in this specification and the appended claims should not be interpreted as being limited to the general meaning and dictionary meaning, but should be interpreted according to the meaning and concept corresponding to the technical aspects of the present invention on the basis of the principle that the inventor is allowed to appropriately define the terms for the best interpretation. Therefore, the descriptions presented here are only preferred examples for illustrative purposes and are not intended to limit the scope of the present invention, so that it should be understood that other equivalents or improvements can be obtained therefrom without departing from the spirit and scope of the present invention.
[0028] In this document, the terms "include", "including", "have", "contain" or any other similar terms are open conjunctions, which are intended to cover non-exclusive inclusions. For example, a composition or product containing multiple elements is not limited to the elements listed herein, but may also include other elements that are not explicitly listed but are generally inherent to the composition or product. In addition, unless otherwise explicitly stated, the term "or" refers to an inclusive "or" rather than an exclusive "or". For example, any of the following situations satisfies the condition "A or B": A is true (or exists) and B is false (or does not exist), A is false (or does not exist) and B is true (or exists), and A and B are both true (or exist). In addition, in this document, the interpretation of the terms "include", "including", "have", and "contain" should be considered to have been specifically disclosed and simultaneously cover closed or semi-closed conjunctions such as "consisting of" and "consisting essentially of".
[0029] In this article, all features or conditions defined in the form of numerical ranges or percentage ranges are only for brevity and convenience. Accordingly, the description of numerical ranges or percentage ranges should be deemed to have covered and specifically disclosed all possible secondary ranges and individual values within the range, especially integer values. For example, the range description of "1 to 8" should be deemed to have specifically disclosed all secondary ranges such as 1 to 7, 2 to 8, 2 to 6, 3 to 6, 4 to 8, 3 to 8, etc., especially secondary ranges defined by all integer values, and should be deemed to have specifically disclosed individual values such as 1, 2, 3, 4, 5, 6, 7, 8, etc. within the range. Unless otherwise specified, the above interpretation method applies to all contents of the entire present invention, regardless of whether the range is broad or not.
[0030] If the quantity or other numerical value or parameter is expressed as a range, a preferred range or a series of upper and lower limits, it should be understood that all ranges consisting of any upper limit or preferred value of the range and the lower limit or preferred value of the range have been specifically disclosed herein, regardless of whether these ranges are disclosed separately. In addition, if a numerical range is mentioned herein, unless otherwise specified, the range should include its endpoints and all integers and fractions within the range.
[0031] In this document, under the premise of achieving the purpose of the invention, numerical values should be understood to have the accuracy of the number of significant digits of the numerical value. For example, the number 40.0 should be understood to cover the range from 39.50 to 40.49.
[0032] The camellia oil skin care cream for babies according to the present invention uses natural camellia oil as one of the main ingredients. Camellia oil contains 80% unsaturated fatty acids, a large amount of fatty acids, sterols, vitamin E and phenolic compounds, and has the effects of anti-inflammatory, anti-oxidation, strengthening and repairing the skin barrier. In addition, the linoleic acid in the fatty acids has obvious effects on anti-inflammation, reducing acne and moisturizing when applied on the skin; the phenolic compounds in camellia oil can inhibit the generation of superoxide anion free radicals in cells, and have the effects of anti-inflammatory, anti-swelling, analgesic and anti-allergic.
[0033] Vitamin E has antibacterial, wound healing and anti-inflammatory effects. Mandarin peel extract and arginine can effectively inhibit the release of histamine in mast cells, strengthen the skin barrier and inhibit the induction of eczema.
[0034] The following examples are only listed as examples of embodiments of the present invention and do not constitute any limitation to the present invention. It can be understood by those skilled in the art that modifications within the scope of the essence and concept of the present invention fall within the scope of protection of the present invention. Unless otherwise specified, the reagents and instruments used in the following examples are all commercially available products.
[0035] Examples 1-3
[0036] The masses of the components in Examples 1-3 were prepared respectively according to Table 1 below.
[0037] Table 1
[0038]
[0039] Prepare the skin care cream as follows:
[0040] 1) Place all components of the polar phase in the same container and stir at 70°C and 5000 rpm to completely dissolve them;
[0041] 2) Place all components of the non-polar phase in another container and stir at 90° C. at a stirring speed of 5000 rpm to mix them evenly;
[0042] 3) mixing the polar phase and the non-polar phase obtained in steps 1) and 2), and continuing to homogenize for 3 minutes, and then treating with a high-pressure homogenizer at 50 MPa to obtain a high-pressure homogenized emulsion;
[0043] 4) The mixed emulsion obtained in step 3) is vacuum degassed and gradually cooled to room temperature to obtain a skin care cream.
[0044] The obtained skin care cream is tested: the test contents include sensory indexes, physical and chemical indexes, hygiene indexes and usage experience evaluation.
[0045] The sensory indicators include: appearance, aroma, and moisturizing effect. The appearance and aroma are judged by visual inspection and smell respectively. Moisturizing effect test: Apply the prepared sample to a glass plate with 3M tape, and place it at 4℃, 25℃, and 37℃ for 8 hours under the condition of maintaining humidity at 50%. The formula of moisturizing rate = (m1 / m0)*100%, where m1 and m0 are the weight of the sample before and after water loss.
[0046] The physical and chemical indicators include heat resistance, cold resistance, and pH, which are measured according to QB / T 1857. Preferably, heat resistance means that there is no oil-water separation after being kept at 40±1°C for 24 hours and then returning to room temperature; pH needs to be in the range of 4.0-8.5; preferably, pH needs to be close to 6.5-7.2.
[0047] Test Example 1: Hygiene index detection of the moisturizing cream in Example 1
[0048] The hygiene indicators include total colony count and mold / yeast, where total colony count is ≤1000 cfu / g and mold / yeast is ≤100 cfu / g, and the measurement is carried out according to the "Technical Specification for Safety of Cosmetics" (2015). Preferably, total colony count is ≤500 cfu / g and mold / yeast is ≤50 cfu / g. The results are shown in Table 2.
[0049] Table 2 Hygiene index test results of moisturizing cream in Example 1
[0050]
[0051] Test Example 2: The samples in Examples 1-3 were tested for their moisturizing properties.
[0052] 1) Apply the prepared sample to a glass plate with 3M tape;
[0053] 2) Under the condition of maintaining humidity at 50%, place it at 4°C, 25°C, and 37°C for 8 hours respectively, and determine the moisture retention rate by the following formula: Moisture retention rate = (m1 / m0)*100%, where m1 and m0 are the weight of the sample before and after water loss, respectively.
[0054] 3) Calculate the moisture retention rate as shown in Table 3 below.
[0055] Table 3 Moisturizing rate of moisturizing cream in implementation case 1-3
[0056]
[0057] Visual inspection and olfactory results: Through observation, the skin care creams prepared in Examples 1 to 3 have a smooth, uniform and consistent cream body and do not have any special smell.
[0058] Heat resistance test: After the samples prepared in Examples 1 to 3 were kept at 40°C for 24 hours and then returned to room temperature, the cream remained almost the same, with no oil-water separation phenomenon, and no obvious shape difference from before the experiment;
[0059] The pH of the prepared skin care creams prepared in Examples 1 to 3 was close to 7.0.
[0060] Test Example 3: Evaluation of the therapeutic effect on infant milk ringworm
[0061] The therapeutic effect of infant milk ringworm was evaluated, and the process was divided into the following steps: selecting cases, applying the invented cream evenly to the affected area 2-3 times a day for 5 consecutive days, observing the affected skin of the patients, and evaluating the therapeutic effect.
[0062] The diagnostic criteria for case selection are erythema, papules, lichenification, scaling, infiltration and hypertrophy, accompanied by varying degrees of itching, with skin lesions distributed on the cheeks; and the skin lesions are located on the head and cheeks and the degree is mild to moderate, without other skin diseases except eczema and milk ringworm, and without systemic diseases. The infants are aged 1 month to 36 months, regardless of gender, and the guardian signs the informed consent form, is willing to follow the test requirements, accept skin testing and return visits on time. Volunteers are not accepted. Children with a history of contact allergy to the test sample, children with local rashes and viral or fungal infections, children with abnormal heart, liver, and kidney function and other serious systemic diseases, children who have used systemic glucocorticoids and immunosuppressants within 4 weeks before the visit, or children who have used glucocorticoids or non-steroidal anti-inflammatory drugs locally within 2 weeks, children who do not use the product according to regulations, automatically terminate treatment or use other drugs during treatment, children with diseases that may affect the skin or current diseases that affect the results of the test, and other dermatologists believe may affect the test results.
[0063] 50 children who met the above case criteria (25 males and 25 females, aged 4-50 months, with a course of disease of 1 day to 1 month) were randomly divided into two groups, an experimental group (skin care cream products of Examples 1 to 3 of the present disclosure) and a control group (ordinary moisturizing liquid: Matsumoto), with 25 people in each group, including 12 males and 13 females in the experimental group (skin care cream products of Examples 1 to 3 of the present disclosure), and 13 males and 12 females in the control group (ordinary moisturizing liquid). The creams of the embodiments of the present invention were applied to the eczema parts of the experimental group, and the ordinary moisturizing liquid was applied to the eczema parts of the control group, 2-3 times a day, for 5 consecutive days, and the skin repair time was recorded. The skin moisturizing rate and dryness, itching, damage, redness, tingling, rash, etc. were evaluated, and the results were statistically analyzed, and the occurrence of discomfort reactions was recorded.
[0064] The child's symptoms were basically gone, and the skin lesions disappeared by more than 90% and were considered cured; the symptoms were significantly improved, and the skin lesions disappeared by more than or equal to 75% and were considered markedly effective; the symptoms were improved to a certain extent, and the skin lesions disappeared by more than 60% and were considered to be improved; no obvious changes in symptoms were considered ineffective, and the number of people with different effects was counted. Specific results are shown in Figure 3 and 4 ,from Figure 3 and 4 It can be seen from the results that the skin care cream according to the present invention has a good healing effect on infant eczema.
[0065] The above is only a specific embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Any person skilled in the art can easily think of changes or substitutions within the technical scope disclosed by the present invention, which should be included in the protection scope of the present invention. Therefore, the protection scope of the present invention should be based on the protection scope of the claims.
Claims
1. A camellia oil skin care cream for babies, comprising a polar phase and a non-polar phase, wherein the polar phase comprises water, glycerin, polyglycerol-6 stearate, sorbitan olivate, 1,2-ethylene glycol, carbomer, vitamin E, and arginine; and the non-polar phase comprises primary camellia oil, cetearyl olivate, caprylic / capric triglyceride, sunflower seed oil, cetearyl alcohol, p-hydroxyacetophenone, and mandarin orange peel extract.
2. The camellia oil skin care cream for babies according to claim 1, characterized in that: Based on 100 parts by weight of the skin care cream, the polar phase includes the following ingredients in parts by weight: 60-80 parts by weight of water, 0.05-5 parts by weight of glycerin, 0.5-5 parts by weight of polyglycerol-6 stearate, 0.5-15.0 parts by weight of sorbitan olive oil ester, 0.05-1 parts by weight of 1,2-ethylene glycol, 0.1-2 parts by weight of carbomer, 0.2-1.8 parts by weight of vitamin E, 0.0 5-0.1 weight parts of arginine; the non-polar phase comprises 2-30 weight parts of first-grade camellia oil, 0.2-1.8 weight parts of cetearyl olive oil ester, 3-7 weight parts of caprylic / capric triglyceride, 0.15-0.3 weight parts of sunflower oil, 0.8-1.7 weight parts of cetearyl alcohol, 0.2-0.5 weight parts of p-hydroxyacetophenone, and 0.1-0.3 weight parts of mandarin orange peel extract.
3. The camellia oil skin care cream for babies according to claim 1, characterized in that: The skin care cream comprises the following ingredients in parts by weight based on 100 parts by weight: 73-78 parts by weight of water, 0.06-0.08 parts by weight of glycerin, 1.5-1.8 parts by weight of polyglyceryl-6 stearate, 0.98-1.50 parts by weight of sorbitan olive oil ester, 0.1-0.3 parts by weight of 1,2-ethylene glycol, 0.15-0.25 parts by weight of carbomer, 0.95-1.6 parts by weight of vitamin E, 0 .07-0.09 weight parts of arginine; the non-polar phase comprises 11-13 weight parts of first-grade camellia oil, 1.1-1.5 weight parts of cetearyl olive oil ester, 4.8-5.2 weight parts of caprylic / capric triglyceride, 0.15-0.3 weight parts of sunflower oil, 0.95-1.3 weight parts of cetearyl alcohol, 0.3-0.4 weight parts of p-hydroxyacetophenone, and 0.1-1 weight parts of mandarin orange peel extract.
4. The method for preparing the camellia oil skin care cream for babies according to claim 1, comprising the following steps: 1) Weighing various ingredients of the skin care cream according to proportion; 2) Mix the components of the polar phase and stir at 70-85°C to completely dissolve them; 3) Mix the components of the non-polar phase and stir at 90-110° C. to make them uniformly mixed; 4) The polar phase and the non-polar phase obtained in steps 2) and 3) are emulsified by mechanical stirring, high-pressure homogenization emulsification, microfluidization emulsification or microfluidic emulsification to form an emulsion, and then the obtained mixed emulsion is vacuum degassed and gradually cooled to 25-50° C. to obtain a skin care cream.
5. The method for preparing the camellia oil skin care cream for babies according to claim 4, characterized in that: The stirring speed of each component of the polar phase in step 2) during the stirring and dissolving process is 4000-7000 rpm.
6. The method for preparing the camellia oil skin care cream for babies according to claim 4, characterized in that: The stirring speed of the non-polar phase during the stirring and dissolving process in step 3) is 5000-8000 rpm.
7. The method for preparing the camellia oil skin care cream for babies according to claim 4, characterized in that: The emulsification method in step 4) is one of high-pressure homogenization emulsification, microfluidization emulsification, and microfluidic emulsification.
8. Use of the camellia oil skin care cream for infants according to any one of claims 1 to 3 as a medicament for treating or alleviating infant eczema.
